RNA-seq analysis from this same study, comparing NFIB-/- to NFIB+/+ prostatic grafts, identified 138 DEGs, some of which, such as FOXC1 and SOX10, are also differential in our analyses of both early PCP samples, and in all normal vs DCIS samples, suggesting a shared role for Nfib in both prostate and mammary epithelial tissue. The gene discussed is NFIB; the disease is ductal breast carcinoma in situ.